Acquisition trends in Indian pharma and the growing focus on oncology portfolios
Indian pharma shifts focus to oncology through strategic acquisitions.
Category: Pharmaceuticals & Healthcare Products
Pharmaceuticals & Healthcare Products
How Indian pharma companies are building strength in immunotherapy and biologics
Indian pharma companies are innovating in immunotherapy breakthroughs.
Global regulatory pressures and how Indian pharma is adapting quality and compliance standards
Indian pharma is evolving to meet global compliance demands.
Pricing pressures versus value growth in therapy segments such as cardiac and diabetes
Balancing pricing pressures with value growth in therapies.
The rising role of specialty drugs and biologics in India’s export mix
India’s specialty drugs are transforming global healthcare exports.
How exporters are managing supply chain risks amid API import dependence
Exporters tackle supply chain risks in a shifting landscape.
Policy environment around medical devices and incentives for growth
Navigating policies can fuel medical device innovation and growth.
The state of clinical trials in India and recent reforms to attract global studies
India’s reforms boost clinical trials, attracting global interest.
Policy reforms shaping India as a manufacturing hub for pharma and devices
India’s policy reforms are transforming its pharma manufacturing landscape.
Quality standards and the quest for compliance with USFDA and EU GMP norms
Navigating USFDA and EU GMP norms ensures product safety.